Muscle response collapse during the Scratch Collapse Test for carpal tunnel syndrome
Official title: Pilot Study, Aimed at Describing in Myography, the Collapse of the Muscular Response Visualized in the Scratch Collapse Test, in Carpal Tunnel Syndrome
Run by Elsan · NCT07248124 · Data updated 2026-11-12
We will try to measure the brief, one-sided loss of muscle strength seen during the Scratch Collapse Test in adults with unilateral carpal tunnel syndrome.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 25 (estimated) |
| Sponsor | Elsan Academic / other |
| Locations | 1 site (Tarbes) |
| Status | Recruiting |
| Started | November 4, 2025 |
| Main results expected | May 4, 2026 |
| Study ends | May 5, 2026 |
| Registry record updated | November 25, 2025 |
| Trial ID | NCT07248124 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 with unilateral carpal tunnel syndrome confirmed by history, exam, and electromyography who can give informed consent and are covered by a social security scheme.
✕Probably not a fit
People with bilateral disease, diabetic or other peripheral neuropathy, associated cervical or other nerve pathology, pregnancy, cognitive impairment, or those unable/unwilling to undergo EMG are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot interventional project uses electromyography (EMG) to record muscle responses while performing the Scratch Collapse Test in adults with clinically and electrically confirmed unilateral carpal tunnel syndrome. Investigators will apply a sensory stimulus over the suspected compression point and record bilateral muscle strength and EMG signals to characterize the transient loss of eccentric muscle tone on the affected side. The protocol excludes people with other neuropathies, diabetes, cervical pathology, or other conditions that could confound nerve conduction or muscle response. The aim is to provide objective, time-resolved measurements of the phenomenon that has previously been described clinically but not quantified with EMG.
Why it matters
Potential benefit: If successful, this could make the Scratch Collapse Test more objective and help clinicians detect and document carpal tunnel nerve compression more reliably.
How similar studies have gone: Clinical reports have described the Scratch Collapse Test's sensitivity and specificity and the cutaneous silent period is a known phenomenon, but no prior study has directly measured the transient unilateral loss of eccentric muscle tone with EMG, making this approach relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient over 18 years old * Patient with clinical unilateral carpal tunnel syndrome diagnosed by history, clinical examination and electromyography, * Patient who has been informed and has given their free, informed, and written consent, * Patient affiliated with or beneficiary of a social security scheme. Exclusion Criteria: * Other associated canal syndrome on either side (ulnar, defilement, lacertus), * Rotator cuff pathology, insufficiency or rupture of the infraspinatus, * Associated cervical pathology, * Neuropathy, central or peripheral neurological disease, * Diabetic patient, * Patient with cognitive impairments that prevent the understanding of the study information, * Refusal to participate in the study, * Pregnant, parturient, or breastfeeding woman, * Patient under legal protection, * Patient not receiving health protection, * Protected patient: adult under guardianship, curatorship, or other legal protection, deprived of liberty by judicial or administrative decision
Where it's running
-
Clinique de l'Ormeau
Tarbes, France Recruiting
Study contacts
- Study coordinator: Vincent Martinel, Dr
- Email: drvmartinel@goop65.fr
- Phone: 0033562563895
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ultrasound-Guided Injection for Carpal Tunnel Syndrome: Hyaluronic Acid vs Corticosteroid vs 5% Glucose
This study tests three ultrasound-guided injections (hyaluronic acid, corticosteroid, and 5% glucose) to see which best helps adults with mild to moderate carpal tunnel syndrome.
-
Open vs ultrasound-guided carpal tunnel release ( CTS )
This study compares two surgical approaches for carpal tunnel syndrome to see which helps people recover better after surgery.
-
Amniotic Membrane and Secretome Added to Carpal Tunnel Release
This trial tests whether adding amniotic membrane and secretome to carpal tunnel surgery helps people with moderate-to-severe CTS recover better than surgery alone.
-
Reliability and validity of hand function tests in carpal tunnel syndrome
This study tests whether three hand function tests (JTHFT, MDT, and Nine-Hole Peg Test) are reliable and valid for people with carpal tunnel syndrome.
-
Neuromobilization, Tendon Gliding, or Both for Mild to Moderate Carpal Tunnel Syndrome
This trial tests whether neuromobilization, tendon gliding exercises, or a combination of both help reduce pain and improve hand function in people with mild to moderate carpal tunnel syndrome.
-
MeDe: Carpal tunnel release with added lacertus release vs carpal tunnel release alone
In adults with carpal tunnel syndrome, this trial tests whether adding a lacertus fibrosus release to the standard carpal tunnel release helps reduce symptoms and improve hand function.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.